Abstract
Current guidelines recommend empiric antifungal therapy in sepsis patients with high risk of invasive Candida infection. However, many different risk factors have been derived from multiple studies. These risk factors lack specificity and broad application would render the majority of ICU patient eligible for empiric antifungal therapy.
Leibniz-HKI-Authors
Identifier
doi: 10.1016/j.chest.2021.08.081
PMID: 34673022